… compounds, repurposed drugs and new technologies. In this Review, we focus on disease-…
We review cellular therapies and repurposed drugs, such as nilotinib, inosine, isradipine, …

… discuss the opportunity for repurposing drugs for use in l-DOPA-induced dyskinesia (LID)
in Parkinson's disease. LID is a particularly suitable indication for drug repurposing given its …

… repurposed drugs that are currently being evaluated in clinical trials for their potential disease…
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a …

… drugs so the disease progresses unchecked. Standard drug discovery programs for disease…
provided key insights into the pathogenesis of Parkinson's disease but, of the many positive …

… Introduction: Parkinson's disease and … of repurposing mitochondria-targeted drugs that are
modifications of natural compounds and FDA-approved drugs for treating Parkinson's disease …

… drug repurposing. With the successful clinical introduction of several repurposed drugs for
Parkinson’s disease, drug repurposing … development of novel drugs for this disease. In this …

… We examined the ICTRP to determine the characteristics of Parkinson’s disease trials … the
history of drug development in Parkinson’s disease, characterize trends in drug development, …

… The most pressing need in Parkinson's disease (PD) clinical practice is … Parkinson's disease
and therefore avoid the onset of the most disabling, dopa-refractory symptoms of the disease…

… We describe strategies of drug repurposing for Parkinson’s disease, which is a
neurodegenerative … properties of drugs used in the treatment of Parkinson's disease. properties of …

… We aimed to develop a drug repurposing pipeline comprising … section, drug repurposing
against Parkinson's disease is not … drug repurposing approach against Parkinson's disease is …